Suppr超能文献

枳椇子-7通过调节肠道微生物群功能改善非小细胞肺癌。

Jidangga-7 ameliorates non-small cell lung cancer by regulating gut microbiota function.

作者信息

Yue Changcheng, San Chula, Deng Shichao, Wang Jingjing, Shen Xueying, Wang Hongqing, Huang Liyan, Bu Renbatu, Wang Dong

机构信息

Affiliated Hospital of Inner Mongolia Minzu University, Tongliao, Inner Mongolia, China.

Clinical Research Centre for Malignant Tumours of Mongolian Medicine in Inner Mongolia Autonomous Region, Tongliao, China.

出版信息

Front Microbiol. 2025 Mar 5;16:1516685. doi: 10.3389/fmicb.2025.1516685. eCollection 2025.

Abstract

OBJECTIVE

This study aims to assess the effects of Jidangga-7 on enhancing gut microbiota function in non-small cell lung cancer.

MATERIALS AND METHODS

Eighteen mice were screened and randomly divided into three groups: a control group, a model group with induced non-small cell lung cancer, and a treatment group receiving Jidangga-7. A549 tumor cells were implanted in the mice, and tumor formation was monitored. Upon successful tumor induction, the treatment group received Jidangga-7 via oral gavage, while the other groups received an equivalent volume of saline. After the final dose, intestinal tissues were collected from each group, and microbial amplicon 16S analysis and non-extensive targeted metabolomics were employed to characterize intestinal fiber and associated metabolites.

RESULTS

By quantifying the contribution of individual species to the variations between the groups, the Sipmer results highlighted the top 10 species and their abundance that contribute to the differences between the two groups. Specifically, Jidangga-7 demonstrated a regulatory effect on various taxa such as Gammaproteobacteria, Bacilli, and Desulfovovoviridae. At the family level, administration of Jidangga-7 exhibited a regulatory effect on families including , , and , compared to the model group. In untargeted metabolomics analyses, principal component analysis effectively differentiated the groups from one another. Subsequently, metabolites with a variable importance in projection score > 1 were screened. The Kyoto Encyclopedia of Genes and Genomes pathway analysis revealed 20 metabolite pathways, encompassing metabolism of cofactors and vitamins, bacterial metabolism, antimicrobial pathways, and xenobiotics biodegradation and metabolism.

CONCLUSION

Jidangga-7 exerted a positive influence on the intestinal microbial environment in mice with non-small cell carcinoma, ameliorating the dysbiosis induced by non- small cell lung cancer. This intervention inhibited the growth of pathogenic bacteria while fostering the growth of beneficial strains.

摘要

目的

本研究旨在评估积当嘎 -7 对增强非小细胞肺癌肠道微生物群功能的作用。

材料与方法

筛选 18 只小鼠并随机分为三组:对照组、诱导非小细胞肺癌模型组和接受积当嘎 -7 的治疗组。将 A549 肿瘤细胞植入小鼠体内,并监测肿瘤形成情况。肿瘤诱导成功后,治疗组通过灌胃给予积当嘎 -7,而其他组给予等量生理盐水。末次给药后,从每组收集肠道组织,并采用微生物扩增子 16S 分析和非广泛靶向代谢组学来表征肠道纤维及相关代谢物。

结果

通过量化各个物种对组间差异的贡献,Sipmer 结果突出了导致两组差异的前 10 个物种及其丰度。具体而言,积当嘎 -7 对γ - 变形菌纲、芽孢杆菌属和脱硫弧菌科等多种分类群具有调节作用。在科水平上,与模型组相比,给予积当嘎 -7 对包括[此处原文缺失部分科名]、[此处原文缺失部分科名]和[此处原文缺失部分科名]在内的科具有调节作用。在非靶向代谢组学分析中,主成分分析有效地将各组区分开来。随后,筛选出投影得分变量重要性>1 的代谢物。京都基因与基因组百科全书通路分析揭示了 20 条代谢物通路,包括辅因子和维生素代谢、细菌代谢、抗菌通路以及异生物质的生物降解和代谢。

结论

积当嘎 -7 对非小细胞癌小鼠的肠道微生物环境产生了积极影响,改善了非小细胞肺癌诱导的生态失调。这种干预抑制了病原菌的生长,同时促进了有益菌株的生长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807a/11919877/0d0d94161cc9/fmicb-16-1516685-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验